厌食症和恶病质的动物模型。
Animal models of anorexia and cachexia.
作者信息
Deboer Mark Daniel
机构信息
Division of Pediatric Endocrinology, University of Virginia.
出版信息
Expert Opin Drug Discov. 2009 Nov 1;4(11):1145-1155. doi: 10.1517/17460440903300842.
Abstract
BACKGROUND
Cachexia is a devastating syndrome of body wasting that worsens quality of life and survival for patients suffering from diseases such as cancer, chronic kidney disease and chronic heart failure. Successful treatments have been elusive in humans, leaving a clear need for the development of new treatment compounds. Animal models of cachexia are able to recapitulate the clinical findings from human disease and have provided a much-needed means of testing the efficacy of prospective therapies. OBJECTIVE: This review focuses on animal models of cachexia caused by cancer, chronic heart failure and chronic kidney disease, including the features of these models, their implementation, and commonly-followed outcome measures. CONCLUSION: Given a dire clinical need for effective treatments of cachexia, animal models will continue a vital role in assessing the efficacy and safety of potential treatments prior to testing in humans. Also important in the future will be the use of animal models to assess the durability of effect from anti-cachexia treatments and their effect on prognosis of the underlying disease states.
摘要
背景
恶病质是一种严重的身体消耗综合征，会降低癌症、慢性肾病和慢性心力衰竭等疾病患者的生活质量并缩短其生存期。人类一直难以找到成功的治疗方法，因此迫切需要开发新的治疗化合物。恶病质动物模型能够重现人类疾病的临床症状，为测试前瞻性疗法的疗效提供了急需的手段。目的：本综述聚焦于由癌症、慢性心力衰竭和慢性肾病引起的恶病质动物模型，包括这些模型的特点、构建方法以及常用的结局指标。结论：鉴于临床上迫切需要有效治疗恶病质的方法，动物模型在评估潜在治疗方法在人体试验前的疗效和安全性方面将继续发挥至关重要的作用。未来，利用动物模型评估抗恶病质治疗效果的持久性及其对基础疾病状态预后的影响也将非常重要。
相似文献
1
Animal models of anorexia and cachexia.厌食症和恶病质的动物模型。
Expert Opin Drug Discov. 2009 Nov 1;4(11):1145-1155. doi: 10.1517/17460440903300842.
2
Update on melanocortin interventions for cachexia: progress toward clinical application.肥胖恶病质的黑素皮质素干预措施的最新进展：向临床应用的推进。
Nutrition. 2010 Feb;26(2):146-51. doi: 10.1016/j.nut.2009.07.003. Epub 2009 Dec 8.
3
Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?生长激素释放肽和恶病质：生长激素促分泌素受体 1a 激动剂的治疗是否会对患有慢性消耗综合征的患者产生影响？
Mol Cell Endocrinol. 2011 Jun 20;340(1):97-105. doi: 10.1016/j.mce.2011.02.012. Epub 2011 Feb 25.
4
Establishing a clinical phenotype for cachexia in end stage kidney disease - study protocol.建立终末期肾病恶病质的临床表型——研究方案
BMC Nephrol. 2018 Feb 13;19(1):38. doi: 10.1186/s12882-018-0819-3.
6
The role of ghrelin in anorexia-cachexia syndromes.生长激素释放肽在厌食-恶病质综合征中的作用。
Vitam Horm. 2013;92:61-106. doi: 10.1016/B978-0-12-410473-0.00003-9.
7
Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia.了解癌症恶病质中厌食症和组织消耗的分子基础。
Exp Mol Med. 2022 Apr;54(4):426-432. doi: 10.1038/s12276-022-00752-w. Epub 2022 Apr 6.
8
Melanocortin interventions in cachexia: how soon from bench to bedside?黑皮质素对恶病质的干预：从实验室到临床应用还需多久？
Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):457-62. doi: 10.1097/MCO.0b013e328108f441.
9
How does cachexia influence survival in cancer, heart failure and other chronic diseases?恶病质如何影响癌症、心力衰竭及其他慢性疾病患者的生存情况？
Curr Opin Support Palliat Care. 2007 Dec;1(4):299-305. doi: 10.1097/SPC.0b013e3282f31667.
10
A Pound of Flesh: What Cachexia Is and What It Is Not.一磅肉：恶病质究竟是什么及不是什么。
Diagnostics (Basel). 2021 Jan 12;11(1):116. doi: 10.3390/diagnostics11010116.
引用本文的文献
1
Modulating the Gut-Muscle Axis: Increasing SCFA-Producing Gut Microbiota Commensals and Decreasing Endotoxin Production to Mitigate Cancer Cachexia.调节肠-肌轴：增加产生短链脂肪酸的肠道微生物共生菌并减少内毒素产生以减轻癌症恶病质。
Microorganisms. 2025 Jun 11;13(6):1356. doi: 10.3390/microorganisms13061356.
2
Resistance Training and Resveratrol Supplementation Improve Cancer Cachexia and Tumor Volume in Muscle Tissue of Male Mice Bearing Colon Cancer CT26 Cell Tumors.抗阻训练和补充白藜芦醇可改善荷结肠癌CT26细胞肿瘤雄性小鼠肌肉组织中的癌症恶病质和肿瘤体积。
Cell Biochem Biophys. 2025 Mar;83(1):619-631. doi: 10.1007/s12013-024-01491-7. Epub 2024 Oct 16.
3
OBSERVE: guidelines for the refinement of rodent cancer models.注意：啮齿类动物癌症模型改良指南。
Nat Protoc. 2024 Sep;19(9):2571-2596. doi: 10.1038/s41596-024-00998-w. Epub 2024 Jul 11.
4
Influence of Amino Acids and Exercise on Muscle Protein Turnover, Particularly in Cancer Cachexia.氨基酸与运动对肌肉蛋白质周转的影响，尤其是在癌症恶病质中的影响。
Cancers (Basel). 2024 May 18;16(10):1921. doi: 10.3390/cancers16101921.
5
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.在癌症恶病质中，FcRn 和肿瘤对免疫检查点抑制剂清除率升高的贡献脱钩。
Pharmacol Res. 2024 Jan;199:107048. doi: 10.1016/j.phrs.2023.107048. Epub 2023 Dec 23.
6
The impact of inflammation and acute phase activation in cancer cachexia.炎症和急性期激活对癌症恶病质的影响。
Front Immunol. 2023 Oct 31;14:1207746. doi: 10.3389/fimmu.2023.1207746. eCollection 2023.
7
Porcine Forebrain Vacuolization Associated with Wasting in Pigs: A Novel Pathological Outcome Associated with Vitamin-Mineral Deficiency?猪前脑空泡化与猪消瘦相关：一种与维生素-矿物质缺乏相关的新病理结果？
Animals (Basel). 2023 Jul 10;13(14):2255. doi: 10.3390/ani13142255.
8
Tricarboxylic acid (TCA) cycle, sphingolipid, and phosphatidylcholine metabolism are dysregulated in infection-induced cachexia.三羧酸（TCA）循环、鞘脂代谢和磷脂酰胆碱代谢在感染诱导的恶病质中失调。
Heliyon. 2023 Jul 5;9(7):e17411. doi: 10.1016/j.heliyon.2023.e17411. eCollection 2023 Jul.
9
The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes.预防途径计划：营养作为预防措施以改善癌症预后。
J Natl Cancer Inst. 2023 Aug 8;115(8):886-895. doi: 10.1093/jnci/djad079.
10
Skeletal muscle omics signatures in cancer cachexia: perspectives and opportunities.癌症恶病质中骨骼肌组学特征：观点与机遇。
J Natl Cancer Inst Monogr. 2023 May 4;2023(61):30-42. doi: 10.1093/jncimonographs/lgad006.
本文引用的文献
1
Update on melanocortin interventions for cachexia: progress toward clinical application.肥胖恶病质的黑素皮质素干预措施的最新进展：向临床应用的推进。
Nutrition. 2010 Feb;26(2):146-51. doi: 10.1016/j.nut.2009.07.003. Epub 2009 Dec 8.
2
Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease.生长激素释放肽和高摄食量的联合作用可增强慢性肾脏病大鼠骨骼肌线粒体氧化能力和 AKT 磷酸化。
Kidney Int. 2010 Jan;77(1):23-8. doi: 10.1038/ki.2009.411.
3
Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging.使用计算机断层扫描和磁共振成像评估兔直肠VX2癌模型
World J Gastroenterol. 2009 May 7;15(17):2139-44. doi: 10.3748/wjg.15.2139.
4
Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice.口服可用的选择性促黑素皮质素-4受体拮抗剂可刺激小鼠的食物摄取并减轻癌症引起的恶病质。
PLoS One. 2009;4(3):e4774. doi: 10.1371/journal.pone.0004774. Epub 2009 Mar 19.
5
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice.用高蛋白、亮氨酸和鱼油的特定组合进行膳食补充可改善荷瘤恶病质小鼠的肌肉功能和日常活动。
Br J Cancer. 2009 Mar 10;100(5):713-22. doi: 10.1038/sj.bjc.6604905.
6
The influence of age and sex on disease development in a novel animal model of cardiac cachexia.年龄和性别对新型心衰动物模型中疾病发展的影响。
Int J Cardiol. 2009 Apr 17;133(3):388-93. doi: 10.1016/j.ijcard.2009.01.060. Epub 2009 Feb 25.
7
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.癌产生的因子通过Toll样受体2（TLR2）激活髓样细胞以刺激转移。
Nature. 2009 Jan 1;457(7225):102-6. doi: 10.1038/nature07623.
8
Modulation of blood pressure by central melanocortinergic pathways.中枢黑皮质素能通路对血压的调节
N Engl J Med. 2009 Jan 1;360(1):44-52. doi: 10.1056/NEJMoa0803085. Epub 2008 Dec 17.
9
Cardiac cachexia: a systematic overview.心脏恶病质：一项系统综述。
Pharmacol Ther. 2009 Mar;121(3):227-52. doi: 10.1016/j.pharmthera.2008.09.009. Epub 2008 Nov 14.
10
Administration of IL-1beta to the 4th ventricle causes anorexia that is blocked by agouti-related peptide and that coincides with activation of tyrosine-hydroxylase neurons in the nucleus of the solitary tract.向第四脑室注射白细胞介素-1β会导致厌食，这种厌食会被刺鼠相关肽阻断，并且与孤束核中酪氨酸羟化酶神经元的激活同时发生。
Peptides. 2009 Feb;30(2):210-8. doi: 10.1016/j.peptides.2008.10.019. Epub 2008 Nov 5.
Zotero 插件